Public Health - Local Drug Overdose Fatality Review Teams - Membership

HB 515 requires that hospital representatives on Maryland's county drug overdose fatality review teams hold specific leadership roles - such as vice president, chief medical officer, or assistant medical officer - instead of any hospital staff member. This change directly affects county-level review teams that analyze overdose deaths, as well as the hospitals participating in them. The bill amends existing law to specify these qualifications for hospital representatives within the team membership structure. It does not create new teams or funding but sets a clearer standard for who can serve in this role. The law takes effect October 1, 2026.